Nivolumab,Ipilimumab
BMS
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
read more from #asco #gu23: cc: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090